Eye game could replace clinic visits for diabetics
NCT ID NCT07386613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether people with diabetes can use a smartphone game to monitor their vision at home, instead of always going to the clinic. 55 participants at high risk for diabetic retinopathy played vision games on their phones for 6 months. The goal was to see if people would stick with the app and if it could catch early signs of eye disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
55 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Jul 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants with type 1 or type 2 diabetes with either no diabetic retinopathy (R0) or early background changes (R1)
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Study 1: * The 55 participants with Type 1 or Type 2 diabetes must also be a gestational, or dialysis DR patient. * Aged 18-70. * All participants should have access to one of the following devices on a daily basis: iPhone (X, XS, XR, 11, 11 Pro, 11 Pro Max, SE 2020, 12, 12 Pro, 12 Pro Max, 12 mini); iPad (Pro 11-inch 2nd generation, Pro 12.9-inch 4th generation); Samsung Galaxy S8, S9, S10, A20e or A40; Samsung Galaxy Tab S3; Honor 10 Lite; Motorola G6 or G7 Power or Pixel 3a. * All participants should also have the ability to read and understand in English and be able to give informed consent. * All participants should also be able to tap the screen of a digital device. * All gestational and dialysis participants should be willing to undergo handheld retinal imaging, no pupil dilation is required. * Be willing to use the app from home for up to 6 months in between the participant's regular clinic visits. Study 2: * The 35 participants with type 1 or type 2 diabetes should have R0 no retinopathy or R1 background changes (this is stated on the letter they receive from the Diabetic Retinal Screening service). * Participants must already have a diabetic screening letter dated within 3 months and use a continuous glucose monitor and be willing to share the data from their monitor with the study team. They must also be willing to allow the research team access to their most recent OCT scans which will be accessed by Prof Tunde Peto. * All participants should have access to one of the following devices on a daily basis: iPhone (X, XS, XR, 11, 11 Pro, 11 Pro Max, SE 2020, 12, 12 Pro, 12 Pro Max, 12 mini); iPad (Pro 11-inch 2nd generation, Pro 12.9-inch 4th generation); Samsung Galaxy S8, S9, S10, A20e or A40; Samsung Galaxy Tab S3; Honor 10 Lite; Motorola G6 or G7 Power or Pixel 3a. * All participants should also have the ability to read and understand in English and be able to give informed consent. * All participants should also be able to tap the screen of a digital device Exclusion Criteria: Study 1 and 2: * The presence of another ocular disease that impacts vision such as age-related macular degeneration, glaucoma, or active uveitis. * Participants who are unable to tap a screen. * Serious life-threatening conditions that would preclude attendance in the longitudinal part of the study. * Neurological conditions that can impair vision * Any physical limitation that would make the participant unable to attend clinic visits (e.g., patients with arthritis or neck problems who may be unable to sit for a prolonged period of time).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes (DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Belfast Health and Social Care Trust, Belfast City Hospital
Belfast, Belfast City, BT97AB, United Kingdom
-
Northern Health and Social Care Trust, Antrim Hospital
Antrim, County Antrim, BT412RL, United Kingdom
-
Southern Health and Social Care Trust, Craigavon Hospital
Craigavon, County Armagh, BT63 5QQ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness and yoga rewire diabetes habits?
- Can cooking classes curb dangerous pregnancy weight gain?
- Home c-peptide tests could reveal hidden insulin production in diabetes
- Can a vegan diet delivered online help people with type 2 diabetes?
- Tiny horses, big lessons: can ponies help kids tame diabetes?
- Gut microbes in pregnancy and infancy: a window into lifelong health?